Nicobrevin for smoking cessation.

Journal article

BACKGROUND: Nicobrevin is a proprietary product marketed as an aid to smoking cessation. It contains quinine, menthyl valerate, camphor and eucalyptus oil. OBJECTIVES: The objective of this review was to assess the effects of Nicobrevin on long term smoking cessation SEARCH STRATEGY: We searched the Cochrane Tobacco Addiction Group trials register. SELECTION CRITERIA: Randomized trials comparing Nicobrevin to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow up. DATA COLLECTION AND ANALYSIS: Data were sought on the outcome, method of randomization, and completeness of follow up. MAIN RESULTS: We identified no trials meeting the full inclusion criteria including long-term follow up. AUTHORS' CONCLUSIONS: There is no evidence available from long-term trials that Nicobrevin can aid smoking cessation.

Authors: Stead, L; Lancaster, T

• Publication status: Published
• Journal: Cochrane database of systematic reviews
• Issue: 2
• Pages: CD005990
• Publication date: 2006-01-01
• DOI: 10.1002/14651858.cd005990
• EISSN: 1469-493X
• ISSN: 1469-493X
• Language: English
• Keywords: Smoking Cessation; Pentanoic Acids; Quinine; Smoking; Terpenes; Humans